Breast Cancer Network NZ is delighted that ERMA has decided to ban the pesticide endosulfan in New Zealand. This chemical is acutely toxic and has hormone-mimicking qualities that are of great concern to Breast Cancer Network. Early exposure of our children and young people to endocrine-disrupting compounds may play an important role in New Zealand’s high incidence of breast cancer. (more…)
Dr. Charles Clevenger and colleagues at Northwestern University have uncovered that cyclophilin B may contribute to progression in breast cancer. Their report can be found in the January 2009 issue of The American Journal of Pathology. The protein cyclophilin B affects cell division, motility, and death, all of which are altered in cancerous cells. To explore the role of cyclophilin B-mediated gene regulation in breast cancer, Dr. (more…)
A Medicare rebate for an MRI breast scan will be available to women under 50 at high risk of breast cancer and with no symptoms from 1 February 2009. Being at high risk of breast cancer can cause significant anxiety. These scans can help reduce unnecessary concern, and help pick up breast cancer early. (more…)
Susan G. Komen for the Cure has awarded Jean Johanna Latimer, Ph.D., assistant professor in the Molecular Genetics and Biochemistry Program at the University of Pittsburgh Cancer Institute (UPCI), a grant to develop biomarkers that will help identify which forms of a common, noninvasive cancer-ductal carcinoma in situ (DCIS)-will metastasize. The research, focusing in part on DCIS in African-American women, may eventually spare patients from unnecessary treatments. (more…)